AU2518592A - Mutated growth factor receptor as medicament and its use for treating cancer - Google Patents

Mutated growth factor receptor as medicament and its use for treating cancer

Info

Publication number: AU2518592A
Authority: AU; Australia
Prior art keywords: medicament; growth factor; treating cancer; factor receptor; mutated growth
Prior art date: 1991-09-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU25185/92A

Other versions

AU669857B2 (en

Inventor

Norbert Redemann

Axel Ullrich

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Max Planck Gesellschaft zur Foerderung der Wissenschaften eV

Original Assignee

Max Planck Gesellschaft zur Foerderung der Wissenschaften eV

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-09-05

Filing date

1992-09-07

Publication date

1993-04-05

1992-09-07 Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV

1993-04-05 Publication of AU2518592A publication Critical patent/AU2518592A/en

1996-06-27 Application granted granted Critical

1996-06-27 Publication of AU669857B2 publication Critical patent/AU669857B2/en

2012-09-07 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

102000009465 Growth Factor Receptors Human genes 0.000 title 1
108010009202 Growth Factor Receptors Proteins 0.000 title 1
206010028980 Neoplasm Diseases 0.000 title 1
201000011510 cancer Diseases 0.000 title 1
239000003814 drug Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

AU25185/92A 1991-09-05 1992-09-07 Mutated growth factor receptor as medicament and its use for treating cancer Ceased AU669857B2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE19914129533 DE4129533A1 (en)	1991-09-05	1991-09-05	MUTTED GROWTH FACTOR RECEPTOR AS A MEDICINAL PRODUCT AND ITS USE FOR TREATING CANCER
DE4129533		1991-09-05
PCT/EP1992/002058 WO1993005148A1 (en)	1991-09-05	1992-09-07	Mutated growth factor receptor as medicament and its use for treating cancer

Publications (2)

Publication Number	Publication Date
AU2518592A true AU2518592A (en)	1993-04-05
AU669857B2 AU669857B2 (en)	1996-06-27

Family

ID=6439926

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU25185/92A Ceased AU669857B2 (en)	1991-09-05	1992-09-07	Mutated growth factor receptor as medicament and its use for treating cancer

Country Status (12)

Country	Link
EP (1)	EP0667899A1 (en)
JP (1)	JPH07502884A (en)
CN (1)	CN1071586A (en)
AU (1)	AU669857B2 (en)
CA (1)	CA2117073A1 (en)
DE (1)	DE4129533A1 (en)
FI (1)	FI941053A (en)
MX (1)	MX9205084A (en)
NO (1)	NO940778L (en)
NZ (1)	NZ244239A (en)
PT (1)	PT100844A (en)
WO (1)	WO1993005148A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996034951A1 (en) *	1995-05-02	1996-11-07	Garvan Institute Of Medical Research	Gdu, a novel signalling protein
US6465623B2 (en)	1995-05-02	2002-10-15	Garvan Institute Of Medical Research	GDU, a novel signalling protein
US7294468B2 (en)	2004-03-31	2007-11-13	The General Hospital Corporation	Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6790614B1 (en)	1999-11-19	2004-09-14	Novartis Ag	Selectable cell surface marker genes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0325224B1 (en) *	1988-01-22	1996-07-31	ZymoGenetics, Inc.	Methods of producing secreted receptor analogs
WO1990008160A1 (en) *	1989-01-20	1990-07-26	Imperial Cancer Research Technology Ltd.	Growth factor receptor-like peptides without tyrosine-kinase activity
GB9001466D0 (en) *	1990-01-23	1990-03-21	Erba Carlo Spa	Extracellular form of the human fibroblast growth factor receptor
CA2055441C (en) *	1989-05-19	2003-01-07	Robert M. Hudziak	Her2 extracellular domain
JP2975679B2 (en) *	1989-09-08	1999-11-10	ザ・ジョーンズ・ホプキンス・ユニバーシティ	Structural change of EGF receptor gene in human glioma

1991
- 1991-09-05 DE DE19914129533 patent/DE4129533A1/en not_active Ceased
1992
- 1992-09-04 PT PT10084492A patent/PT100844A/en not_active Application Discontinuation
- 1992-09-04 MX MX9205084A patent/MX9205084A/en unknown
- 1992-09-05 CN CN 92111396 patent/CN1071586A/en active Pending
- 1992-09-07 WO PCT/EP1992/002058 patent/WO1993005148A1/en not_active Application Discontinuation
- 1992-09-07 EP EP92918949A patent/EP0667899A1/en not_active Withdrawn
- 1992-09-07 NZ NZ24423992A patent/NZ244239A/en unknown
- 1992-09-07 CA CA 2117073 patent/CA2117073A1/en not_active Abandoned
- 1992-09-07 AU AU25185/92A patent/AU669857B2/en not_active Ceased
- 1992-09-07 JP JP5504969A patent/JPH07502884A/en active Pending
1994
- 1994-03-04 FI FI941053A patent/FI941053A/en not_active Application Discontinuation
- 1994-03-04 NO NO940778A patent/NO940778L/en unknown

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996034951A1 (en) *	1995-05-02	1996-11-07	Garvan Institute Of Medical Research	Gdu, a novel signalling protein
US6465623B2 (en)	1995-05-02	2002-10-15	Garvan Institute Of Medical Research	GDU, a novel signalling protein
US7294468B2 (en)	2004-03-31	2007-11-13	The General Hospital Corporation	Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
US7964349B2 (en)	2004-03-31	2011-06-21	The General Hospital Corporation	Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
US8105769B2 (en)	2004-03-31	2012-01-31	The General Hospital Corporation	Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
US8465916B2 (en)	2004-03-31	2013-06-18	The General Hospital Corporation	Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
AU2012202668B2 (en) *	2004-03-31	2015-02-05	Dana-Farber Cancer Institute, Inc.	Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
US9035036B2 (en)	2004-03-31	2015-05-19	The General Hospital	Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
AU2015201692B2 (en) *	2004-03-31	2017-03-02	Dana-Farber Cancer Institute, Inc.	Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
US10000815B2 (en)	2004-03-31	2018-06-19	The General Hospital Corporation	Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
US10669589B2 (en)	2004-03-31	2020-06-02	The General Hospital Corporation	Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments

Also Published As

Publication number	Publication date
DE4129533A1 (en)	1993-03-11
CN1071586A (en)	1993-05-05
MX9205084A (en)	1993-05-01
NO940778D0 (en)	1994-03-04
FI941053A (en)	1994-04-08
EP0667899A1 (en)	1995-08-23
FI941053A0 (en)	1994-03-04
NZ244239A (en)	1995-07-26
JPH07502884A (en)	1995-03-30
NO940778L (en)	1994-05-04
WO1993005148A1 (en)	1993-03-18
AU669857B2 (en)	1996-06-27
CA2117073A1 (en)	1993-03-18
PT100844A (en)	1994-05-31

Publication	Publication Date	Title
AU2845492A (en)	1993-05-27	Dipyridamole for the treatment of proliferative diseases
AU2187992A (en)	1993-01-08	Composition and method for disease treatment
AU6276194A (en)	1994-09-26	Use of monoterpenes, sesquiterpernes and diterpernes for the treatment of cancer
AU1966992A (en)	1993-01-21	Skin treatment system
AU2186792A (en)	1993-06-28	Patient sling
AU7272196A (en)	1998-05-15	Use of hyaluronan in gene therapy
AU2898989A (en)	1989-08-03	Human platelet-derived growth factor receptor
AU8487191A (en)	1992-04-09	2-aminopyrimidine-4-caroxamide derivatives, their preparation and their use in therapy
AU1433292A (en)	1992-11-02	Material treatment apparatus
AU3892593A (en)	1993-11-18	Composition for therapeutic or diagnostic use, process for its preparation and its use
AU5590696A (en)	1996-08-08	Use of quinones in the treatment of cancer or AIDS
AU2490492A (en)	1993-03-16	Process for the preparation of beta-phenylisoserine derivatives and use thereof
AU2461792A (en)	1993-02-11	Monitor for growth and deposit
AU3030192A (en)	1993-06-24	Lip treatment composition
AU1097192A (en)	1992-08-20	Treatment of particulate material
AU7793791A (en)	1991-11-27	Pharmaceutical composition for use in treating pain
AU2518592A (en)	1993-04-05	Mutated growth factor receptor as medicament and its use for treating cancer
EP0556671A3 (en)	1993-09-15	Triazolopyridine derivatives, process for their preparation and their use as microbicides
AU1507992A (en)	1992-10-29	2-aminopyrimidine-4-carboxamide derivatives, their preparation and their application in therapy
SG54230A1 (en)	1998-11-16	Human platelet-derived growth factor receptors
AU4324089A (en)	1990-04-18	Peptide antagonists for use in cancer therapy, and the use of mas oncogene and its product
AU7770991A (en)	1991-11-27	Method and composition for the treatment of cancer
ZA922073B (en)	1992-11-25	New compounds for use in the treatment of cancer
AU2353092A (en)	1993-03-18	Substituted aminopropanes, processes for their preparation, and their use
AU4980693A (en)	1994-04-12	Improvements in skin plasters